his and hers compounded semaglutide Novo Nordisk calls out dangers of GLP-1s in new ad Hims & Hers Stock Tumbles

Clinically Proven Technology We use only evidence-based devices and injectables chosen for real outcomes, not trends

Az Eurpai Gygyszergynksg (EMA) fellvizsglatot vgzett, s nem tallt bizonytkot arra, hogy a szles krben hasznlt slycskkent s cukorbetegsg elleni gygyszerek kapcsolatban llnnak a pajzsmirigyrkkal rja a Bloomberg

they take up or degrade neurotransmitters, regulate synaptic connectivity, release various factors with gland-like properties and even contribute to high-order cognitive functions through their integration within neuronal circuits

A separate 2025 trial in NEJM Evidence (Shah et al.) in adults with T1D and obesity on AID found that around one in three semaglutide-treated participants met a combined goal of improved time in range, low hypoglycemia, and at least 5% weight loss